Détail de l'auteur
Auteur F. SCHIFANO |
Documents disponibles écrits par cet auteur (55)
Article : Périodique
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE |2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]Article : Périodique
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO |OBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]Périodique
F. SCHIFANO ; L. MICONI ; GALLIMBERTI L. | 1994FRANÇAIS : Description d'un cas de dépendance à la trimébutine, antispasmodique musculotrope.Congrès
F. SCHIFANO ; FORZA G. ; CANEVA A. ; GALLIMBERT L. ; FERRARA S. D. | 1993L'ecstasy devient de plus en plus populaire en Italie du Nord. Le MDMA a des propriétés hallucinogènes et excitantes. L'usage d'ecstasy semble provoquer aussi anxiété, insomnie, crises de paranoïa, confusion. Deux cas sont présentés ici (psychop[...]Article : Périodique
Cocaine-related deaths have increased since the early 1990s in Europe, including the UK. Being multi-factorial, they are difficult to define, detect and record. The European Monitoring Centre for Drugs and Drug Addiction commissioned research to[...]Article : Périodique
RATIONALE: The issue of ecstasy-related fatalities has extensively attracted the attention of both the media and the general public, but less so of the scientific literature. OBJECTIVES: The aim of the present review is to focus on the epidemiol[...]Article : Périodique
F. SCHIFANO ; J. CORKERY ; E. GILVARRY ; P. DELUCA ; A. OYEFESO ; A. H. GHODSE |Buprenorphine safety in overdose has been debated recently, but no mortality data related to this compound from the UK have been published. To gather together all of the buprenorphine mortality figures, a number of different sources have been ch[...]Article : Périodique
A recent trend of escalating use of cocaine/crack cocaine was observed in the UK. The number of mentions on death certificates; last year use of cocaine; treatment demand, number of drug offenders, seizures, prices and average purity levels were[...]Article : Périodique
B. LOI ; J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; S. CHIAPPINI ; C. GIMENO CLEMENTE ; F. SCHIFANO |Objective: Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst 16- to 24-year-olds [...]Périodique
O. CORAZZA ; F. SCHIFANO ; M. FARRE ; P. DELUCA ; Z. DAVEY ; C. DRUMMOND ; M. TORRENS ; Z. DEMETROVICS ; L. DI FURIA ; L. H. FLESLAND ; B. MERVO ; J. MOSKALEWICZ ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; C. PEZZOLESI ; P. VAN DER KREEFT ; N. SCHERBAUM | 2011Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-[...]Article : Périodique
V. REISSNER ; A. KOKKEVI ; F. SCHIFANO ; R. ROOM ; J. STORBJÖRK ; R. STOHLER ; L. DiFURIA ; J. REHM ; M. GEYER ; F. HÖLSCHER ; N. SCHERBAUM |Objectives: This comparative study investigated consumption patterns, comorbidity and treatment utilization of opioid addicts in six European cities (Athens, Essen, London, Padua, Stockholm, Zurich). Subjects and methods: Data were collected b[...]Rapport
H. GHODSE ; J. CORKERY ; A. OYEFESO ; F. SCHIFANO | London : International Centre for Drug Policy, St George's University of London | 2008Notifications of 1,539drug-related deaths occurring in 2007 were received by the Programme. A total of 107 coroners from 115 jurisdictions in England & Wales, as well as from Northern Ireland, the Channel Islands and Isle of Man, together with o[...]Rapport
H. GHODSE ; J. CORKERY ; A. OYEFESO ; F. SCHIFANO ; K. AHMED ; V. NAIDOO | London : International Centre for Drug Policy, St George's University of London | 2009The National Programme on Substance Abuse Deaths (np-SAD) principal aim is to contribute to the reduction and prevention of drug-related deaths in the UK due to the misuse of drugs, both licit and illicit, by collecting, analysing and disseminat[...]Rapport
H. GHODSE ; J. CORKERY ; K. AHMED ; V. NAIDOO ; A. OYEFESO ; F. SCHIFANO | London : International Centre for Drug Policy, St George's University of London | 2010ENGLISH : This eleventh annual report presents information on drug-related deaths that occurred during 2009 and for which Coronial inquests and similar formal investigations have been completed. The main purpose of the Annual Report from the n[...]Rapport
J. CORKERY ; H. CLARIDGE ; B. LOI ; C. GOODAIR ; F. SCHIFANO | London : International Centre for Drug Policy, St George's University of London | 2014FRANÇAIS : Meow, meow, Benzo Fury, PMA figurent aujourd'hui parmi celles que l'on appelle les nouvelles substances psychoactives (Novel Psychoactive Substances) responsables d'un nombre de décès croissant en Grande Bretagne : 10 décès en 2009 c[...]Article : Périodique
F. SCHIFANO ; P. DELUCA ; A. BALDACCHINO ; T. PELTONIEMI ; N. SCHERBAUM ; M. TORRENS ; M. FARRE ; FLORES I. ; M. ROSSI ; D. EASTWOOD ; GUIONNET C. ; S. RAWAF ; L. AGOSTI ; L. DI FURIA ; BRIGADA R. ; A. MAJAVA ; H. SIEMANN ; LEONI M. ; TOMASIN A. ; ROVETTO F. ; A. H. GHODSE ; Psychonaut 2002 Research Group |PURPOSE: Only a few formal assessments of websites with drug-related contents have been carried out. We aimed here at fostering collection and analysis of data from web pages related to information on consumption, manufacture and sales of psycho[...]Article : Périodique
BACKGROUND: "Legal highs" are becoming increasingly common features of the recreational drug market. The Internet has emerged as an important resource for technical and pharmacological knowledge in the absence of evidence-based literature, and f[...]Article : Périodique
F. SCHIFANO ; J. CORKERY ; P. DELUCA ; A. OYEFESO ; A. H. GHODSE |In the last decade, a global trend of escalating ecstasy (MDMA, MDA, MDEA, MBDB) use was observed. Mentions on medical death certificates, last year's ecstasy use, number of drug offenders, seizures, prices and dosage levels figures were used fo[...]Article : Périodique
A. OYEFESO ; F. SCHIFANO ; H. GHODSE ; K. COBAIN ; DRYDEN R. ; J. CORKERY |BACKGROUND: Studies of drug-related mortality rarely describe fatal injuries due to psychoactive drug intoxication (FIUI). The main aim of this study was to determine the nature, extent and pattern of FIUI. METHODS: This observational study cove[...]Article : Périodique
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine
O. CORAZZA ; S. ASSI ; F. SCHIFANO |This article reviews the recreational use of ketamine ("Special K"; KET) and explores the recent diffusion of its new derivative methoxetamine ("Special M"; MXE). The literature search on the nonclinical/recreational use of KET and MXE was carri[...]Article : Périodique
Novel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy-makers and clinicians are under-informed about appropr[...]Article : Périodique
P. DELUCA ; Z. DAVEY ; O. CORAZZA ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. MANNONEN ; A. MAJAVA ; T. PELTONIEMI ; M. PASINETTI ; C. PEZZOLESI ; N. SCHERBAUM ; H. SIEMANN ; A. SKUTLE ; M. TORRENS ; P. VAN DER KREEFT ; E. IVERSEN ; F. SCHIFANO |BACKGROUND: This paper presents the outcomes of the 2-year European Union funded Psychonaut Web Mapping Project which aimed at developing and implementing an integrated web mapping system to promptly identify and learn about novel psychoactive s[...]Article : Périodique
V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO |COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]Article : Périodique
F. SCHIFANO ; LEONI M. ; G. MARTINOTTI ; S. RAWAF ; ROVETTO F. |What do therapy and cybertherapy need to take into account to be effective for the treatment of drug-related disorders? The Psychonaut 2002 project is aimed to create a new and updated Web-based tool, which will be based on evolving drug scenari[...]Article : Périodique
We would like to highlight the necessity of reflecting and possibly reconsidering the use of term 'legal highs' in the field of drug prevention and research, as it refers to two ambiguous and undefined characteristics of these products. [Extract]